These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 29159804)
1. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor. Schroeder L; Wichmann G; Willner M; Michel A; Wiesenfarth M; Flechtenmacher C; Gradistanac T; Pawlita M; Dietz A; Waterboer T; Holzinger D Int J Cancer; 2018 Apr; 142(7):1361-1368. PubMed ID: 29159804 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study. Schroeder L; Boscolo-Rizzo P; Dal Cin E; Romeo S; Baboci L; Dyckhoff G; Hess J; Lucena-Porcel C; Byl A; Becker N; Alemany L; Castellsagué X; Quer M; León X; Wiesenfarth M; Pawlita M; Holzinger D Eur J Cancer; 2017 Mar; 74():73-81. PubMed ID: 28335889 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084 [TBL] [Abstract][Full Text] [Related]
4. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay. Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236 [TBL] [Abstract][Full Text] [Related]
6. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary. Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564 [TBL] [Abstract][Full Text] [Related]
7. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy. Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059 [TBL] [Abstract][Full Text] [Related]
8. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381 [TBL] [Abstract][Full Text] [Related]
9. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck. Beadle BM; William WN; McLemore MS; Sturgis EM; Williams MD Head Neck; 2013 Nov; 35(11):1527-33. PubMed ID: 23108906 [TBL] [Abstract][Full Text] [Related]
10. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928 [TBL] [Abstract][Full Text] [Related]
11. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis. Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171 [TBL] [Abstract][Full Text] [Related]
12. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407 [TBL] [Abstract][Full Text] [Related]
14. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
15. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary. Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841 [TBL] [Abstract][Full Text] [Related]
16. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site. Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345 [TBL] [Abstract][Full Text] [Related]
17. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Mehrad M; Carpenter DH; Chernock RD; Wang H; Ma XJ; Luo Y; Luo J; Lewis JS; El-Mofty SK Am J Surg Pathol; 2013 Sep; 37(9):1349-56. PubMed ID: 23797720 [TBL] [Abstract][Full Text] [Related]
18. Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection. Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Weiss D; Koopmann M; Rudack C Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]